<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">84</article-id>
<title-group><article-title>An overview on breast cancer</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Kumari</surname><given-names>Pushpa</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Santosh</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author"><name><surname>Shukla</surname><given-names>Bhanu Pratap</given-names></name><xref ref-type="aff" rid="aff3"/></contrib>
<contrib contrib-type="author"><name><surname>Dubey</surname><given-names>Anubhav</given-names></name><xref ref-type="aff" rid="aff4"/></contrib>
<aff id="aff1"><label>1</label>Assistant Professor, Department of Pharmaceutics, Naraina Vidya Peeth Group of Institutions Panki Kanpur, Uttar Pradesh, India</aff>
<aff id="aff2"><label>2</label>Research Scholar Department of Pharmacognosy, Advance Institute of Biotech and Paramedical Sciences Kanpur, Uttar Pradesh, India</aff>
<aff id="aff3"><label>3</label>Research Scholar Department of Pharmaceutics, Advance Institute of Biotech and Paramedical Sciences Kanpur, Uttar Pradesh, India</aff>
<aff id="aff4"><label>4</label>Assistant Professor, Department of Pharmacology, Maharana Pratap College of Pharmacy Kanpur, Uttar Pradesh, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2021</year></pub-date>
<volume>2</volume>
<issue>3</issue>
<fpage>59</fpage>
<lpage>65</lpage>
<history>
<date date-type="received"><day>09</day><month>08</month><year>2021</year></date>
<date date-type="accepted"><day>26</day><month>08</month><year>2021</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/84/an-overview-on-breast-cancer"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/84/download"/>
<abstract><p>The aim of this study was to give a brief explanation about Breast Cancer, its causes, factors that cause breast cancer, diagnosis, treatment, etc. in India and in World. Also given a brief description of Cancer, and its types. Breast cancer is the most common female cancer in the world, Breast cancer incidence is rising all over the world, at different rates. Many clinical and genetic factors have been found to increase a womanâ€™s risk of developing the disease. Current strategies to decrease a womanâ€™s risk of developing breast cancer include primary prevention, such as avoiding tobacco, exogenous hormone use and excess exposure to ionizing radiation, maintaining a normal weight, exercise, breastfeeding, eating a healthy diet and minimizing alcohol intake. The objective of this study was too aware the women from various causes of breast cancer.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Breast cancer</kwd><kwd>Gene Therapy</kwd><kwd>Breastfeeding</kwd><kwd>Diagnosis</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Anubhav Dubey, Deepanshi Tiwari, Yatendra Singh, Om Prakash, Pankaj Singh. Drug repurposing in Oncology: Opportunities and challenges. Int J of Allied Med Sci and Clin Res. 2021; 9(1):68-87.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5):E359 E386.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Nikolic S, Oprich M. Proliferative diseases of the breast, Komerc print, Belgrade, 1990.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Ebeid NI. Egyptian Medicine in the Days of the Pharaohs; General-Egyptian Book Organization: Cairo, Egypt, 1999; ISBN 9789770164228.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Siegel RL, Miller KD, Fuchs HE, Jemal, A. Cancer Statistics, 2021. CA A Cancer J. Clin. 2021; 71:7-33.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Duncan W, Kerr GR. The curability of breast cancer. Br. Med. J. 1976; 2:781-783.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Juanpere S, Perez E, Huc O, Motos N, Pont J, Pedraza S. Imaging of breast implants-a pictorial review. Insights Into Imaging. 2011; 2:653-670.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Basilion J. Breast imaging technology: Current and future technologies for breast cancer imaging. Breast Cancer Res. 2001; 3:13-14.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Iranmakani S, Mortezazadeh T, Sajadian F, Ghaziani MF, Ghafari A, Khezerloo D, et al. A review of various modalities in breast imaging: Technical aspects and clinical outcomes. Egypt. J. Radiol. Nucl. Med. 2020; 51:57.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Zhang XH, Xiao C. Diagnostic Value of Nineteen Different Imaging Methods for Patients with Breast Cancer: A Network Meta-Analysis. Cell. Physiol. Biochem. 2018; 46:2041-2055.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Hashim D, Boffetta P, La Vecchia C, et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol. 2016; 27(5):926-933.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380(9855):1778-1786.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014; 311(13):1327-1335.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Moja L, Tagliabue L, Balduzzi S, et al. Trastuzumab containing regimens for early breast cancer. Cochrane Database Syst Rev. 2012; 4:CD006243.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Rath GK. Radiation Therapy in the Management of Cancer. 50 Years of Cancer Control in India. [21 Mar 2010]</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Detailed guide. Breast cancer radiation therapy. American cancer society. 2009. Sep 18, [21 Mar 2010].</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Wells BG. 5th ed. New Delhi: Tata McGraw hill publishing company limited; 2004. Breast Cancer, Pharmacotherapy hand book.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Mukherjee S, Koner BC, Ray S, Ray A. Environmental contaminants in pathogenesis of breast cancer. Indian J Exp Biol. 2006; 44(8):597-617.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Society AC. Breast Cancer. NCCN Guidel Breast Cancer Patients, 2017, 6.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Thomson AK, Heyworth JS, Girschik J, Slevin T, Saunders C, et al. Beliefs and perceptions about the causes of breast cancer: A case-control study. BMC Res. 2014; 7:1-8.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Matthews SB, Thompson HJ. The obesity breast cancer conundrum: An analysis of the issues. Int J Mol Sci. 2016; 17:6.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Langer A, Mohallem M, Berment H, Ferreira F, Gog A, et al. Breast lumps in pregnant women. Diagn Interv Imaging. 2015; 96(10):1077-1087.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Rubenstein S Breast Lumps. JAMA: The Journal of the American Medical Association. 1976; 235:1689.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>Baraza R. Breast lumps. East African Medical Journal. 1992; 69(5):229-230.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>Boykx P, Li J, Gavens L, Lovatt M, Gomes de Matos E, et al. An investigation of public knowledge of the link between alcohol and cancer. Univ Sheff Cancer Res UK, 2015.</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Lawlor DA, Ebrahim S, Davey Smith G. Smoking before the birth of a first child is not associated with increased risk of breast cancer: Findings from the British Women’s Heart and Health Cohort Study and a meta-analysis. Br J Cancer. 2004; 91(3):512-518.</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>Tanaka T, Decuzzi P, Cristofanilli M, Sakamoto JM, Tasciotti V, Robertson FM, Ferrari M. Nanotechnology for breast cancer therapy. Biomed Microdevices. 2009; 11:49-63.</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Clark GM, McGuire WL. Progesterone receptors and human breast cancer. Breast cancer research and treatment. 1983; 3:157-163.</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Weber G, Chamorro CI, Granath F, Liljegren A, Zreika S, Saidak Z, et al. Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast cancer research. 2011; 11:R6.</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Borggist S, Jogi A, Ponten F, Ryden L, Brennan DJ, Jirstrom K. Prognostic impact of tumor-specific HMG-CoA reductase expression in primary breast cancer. Breast cancer research. 2008; 10:R79.</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>Chang L, Graham P, Hao J, et al. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy. Cancer Lett. 2015; 369(2):289-297.</mixed-citation></ref>
<ref id="R32"><label>32</label><mixed-citation>Burstein HJ, Temin S, Anderson H, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol. 2014; 32(21):2255-2269.</mixed-citation></ref>
<ref id="R33"><label>33</label><mixed-citation>Goss PE, Ingle JN, Pritchard KI, et al. A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer. J Clin Oncol. 2016; 34(Suppl) LBA1.</mixed-citation></ref>
</ref-list></back>
</article>